Search research articles
Contact Us
Filters
Showing results (201-210 of 223) with videos related to
Page
of 23
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment
Sara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Head & Neck
|
July 29, 2024
Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel-plus-cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Beatriz Cirauqui Cirauqui, Adrià Bernat Peguera, Ariadna Quer Pi-Sunyer, et al.
Ebiomedicine
|
March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Bruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries
, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)
|
September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
, Maile Ray, Roger Logan, et al.
AIDS (London, England)
|
May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
Lauren E Cain, Andrew Phillips, Sara Lodi, et al.
Journal of Eating Disorders
|
June 10, 2026
Specialized, integrative treatment for long-standing eating disorders: early insights and implications
Fernando Fernández-Aranda, Nuria Jaurrieta, Karla Fernández de Betoño, et al.
Medicine
|
October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
Lauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Neuro-Oncology
|
April 25, 2020
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, et al.
American Journal of Hematology
|
March 7, 2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
Eva Gonzalez Barca, Laura Tomás-Roca, Anna Esteve, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 223) with videos related to
Sort By:
Page
of 23
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment
Sara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Head & Neck
|
July 29, 2024
Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel-plus-cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Beatriz Cirauqui Cirauqui, Adrià Bernat Peguera, Ariadna Quer Pi-Sunyer, et al.
Ebiomedicine
|
March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Bruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries
, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)
|
September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
, Maile Ray, Roger Logan, et al.
AIDS (London, England)
|
May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
Lauren E Cain, Andrew Phillips, Sara Lodi, et al.
Journal of Eating Disorders
|
June 10, 2026
Specialized, integrative treatment for long-standing eating disorders: early insights and implications
Fernando Fernández-Aranda, Nuria Jaurrieta, Karla Fernández de Betoño, et al.
Medicine
|
October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
Lauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Neuro-Oncology
|
April 25, 2020
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, et al.
American Journal of Hematology
|
March 7, 2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
Eva Gonzalez Barca, Laura Tomás-Roca, Anna Esteve, et al.
Page
of 23